MEDGm vs EverPrime
Both clinics sit in our top 10, so this page exists for readers already comparing them here. It is not written for search and is not submitted for indexing. Every figure below is read from the clinic's own page, with the date.
26 of the 51 clinics we rank are an affiliate partner. Scores come only from our published methodology. At equal displayed scores, active affiliate partners are listed first. What it changes is which clinic a promoted button points at, and every such link carries a PICK badge in the table so you can see it before you click.
PickPublishes every plan length with its total billed and its per-month rate on each product page, and covers more routes than any clinic here. But the $169/mo headline is $2,028 charged up front and non-refundable.
from $169/mo on a $2,028 prepaid year
Verified 2026-09-16
Visit →Affiliate link
Enhance.MD, LLC's second storefront: compounded semaglutide at $214 a month on a 12-month plan paid up front, with a video visit, labs every six months and named pharmacies and medical groups. Its "from $115" headline needs a $99 monthly membership that brings the total back to $214, and it publishes no list of the states it serves.
from $214/mo on the 12-month plan, paid upfront
Verified 2026-10-30
Visit →Affiliate link
| MEDGm | EverPrime | |
|---|---|---|
| Price | from $169/mo on a $2,028 prepaid yearTheir page, read 2026-09-16 | from $214/mo on the 12-month plan, paid upfrontTheir page, read 2026-10-30 |
| Price shape | one-ongoing-rate | one-ongoing-rate |
| What the price doesn’t say | $169/mo only exists on the 12-month plan, and the $2,028 is charged up front and non-refundable. Month to month is $299, or $179 for a first month with the published code. | $214/mo is the 12-month plan for compounded semaglutide, paid up front ($2,568 in the price list EverPrime's sign-up flow loads). Shorter plans are $224/mo (6 months), $237/mo (3 months) and $249 for one month. The "from $115" EverPrime advertises is the member price, which needs its $99/mo membership on top; the page's own member total is also $214/mo on 12 months. Read 30 October 2026. |
| What it covers | 12 months of compounded semaglutide at any dose, labs and metabolic report, provider consultation, dose adjustments, side-effect medications and shippingTheir page, read 2026-09-16 | Not published. The page does not say what the figure covers.Their page, read 2026-10-30 |
| Billed on top | Nothing on the compounded plans. Labs, shipping and side-effect medication are included. On the three brand-name routes the published figure is a membership only ($99 Zepbound/Wegovy, $171 Ozempic) and the medication cost is not published.Their page, read 2026-09-16 | Compare our membership plans: "Provider Oversight" ... "Treatment visits, $99/visit" in the non-member column, while the semaglutide page lists "Initial video visit with a licensed provider" and "Ongoing treatment review and provider support" as includedTheir page, read 2026-10-30 |
| Commitment | Committed term. The rate applies on a $2,028 prepaid year. Billed up front on that term. What happens after the first period: Publishes a full term grid with the first month priced separately: "$597 → $199/mo billed every 3 months", "$1,134 → $189/mo billed every 6 months", "$2,028 → $169/mo billed every 12 months", alongside "First month $179". The ongoing rate is the tier, and the entry price is labelled as the entry price. (Read at source 2026-09-18.).Their page, read 2026-09-16 | Committed term. The rate applies on the 12-month plan, paid upfront.Their page, read 2026-10-30 |
| Routes | compounded semaglutide, compounded tirzepatide, compounded semaglutide tablet, brand-name Zepbound, brand-name Wegovy pill, brand-name Wegovy pen, brand-name Ozempic | compounded semaglutide, compounded tirzepatide, compounded semaglutide + tirzepatide, microdosing |
| Score | 7.9 | 6.8 |
What one does that the other doesn’t
MEDGm
Offers oral/sublingual, brand-name where EverPrime does not.
EverPrime
Offers other where MEDGm does not.
Who each one suits
Every line below is a difference we can measure, with the field or criterion it comes from. Where a side is empty, nothing in what we record favours it. We would rather say that than invent a reason.
MEDGm
- Lower published entry figure of the two.Basis: published entry price, each in its own billing unit
- Only one of the two offering: oral/sublingual, brand-name.Basis: published treatments, by drug and route
- Scores clearly higher on transparency (7.5 vs 5.0).Basis: our published scoring rubric
- Scores clearly higher on pricing (7.0 vs 6.0).Basis: our published scoring rubric
EverPrime
- Only one of the two offering: other.Basis: published treatments, by drug and route